Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

6.950 +0.210 (+3.12%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Angiodynamics Inc

< Previous 1 2 3 4 5 Next >
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
Should investors add these stocks on their watchlist? Insider buys suggest so. 
Via Talk Markets
4 Analysts Assess AngioDynamics: What You Need To Know
Via Benzinga
Nasdaq Moves Lower; Levi Strauss Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
Via Benzinga
Exposures Fossil Fuels
Why AngioDynamics Stock Is Crashing Today
Investors didn't like the medical technology company's fiscal 2025 Q1 update. 
Via The Motley Fool
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Via Benzinga
US Stocks Staring At Another Weak Open As Traders Await Key Jobs Report; Sentiment Wavers As Oil Extends Surge Amid Middle East Tensions
Sentiment continues to be cautious as traders play the “wait-and-watch” game until they see off Friday’s non-farm payroll data. The index futures traded moderately lower early Thursday. 
Via Benzinga
Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings
Via Benzinga
S&P Settles Slightly Higher Despite Middle East Concerns: Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
Via Benzinga
Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 million, driven by strong performance in the Med Tech segment. The company... 
Via Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024
ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Insiders Buying Zumiez And 3 Other Stocks
Although U.S. stocks closed little changed on Monday, there were a few notable insider trades. 
Via Benzinga
Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens treatment options. Sales slightly below consensus, but pro forma basis sees... 
Via Benzinga
Exposures Product Safety
ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024
ANGO stock results show that AngioDynamics missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning! 
Via InvestorPlace
Earnings Scheduled For April 4, 2024
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. 
Via Benzinga
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities. 
Via InvestorPlace
AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
The medical device maker's shares have seen an increase of 1.49% over the last month, not keeping up with the Medical sector's gain of 2.05% and the S&P 500's gain of 5.07%. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know
Via Benzinga
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why AngioDynamics Stock Got Destroyed Today
The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected. 
Via The Motley Fool
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Applied Therapeutics, Inc. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.